ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 001,80
-0,48%
Dow Jones
38 798,99
-0,22%
DAX
18 557,27
-0,48%
Brent Oil
79,395
-0,61%
Bitcoin
69 304,58
-2,06%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Shattuck Labs Inc (STTK)

  7. Shattuck Labs Inc (STTK) Actualités

STTK

Shattuck Labs (STTK)

Shattuck Labs Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:STTK
DateHeureSourceTitreSymboleSociété
06/06/202413h30GlobeNewswire Inc.Shattuck Labs to Host Investor Call and Webcast on Additional Interim Data Presented at the European Hematology Association (EHA) 2024 Congress from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk MyeNASDAQ:STTKShattuck Labs Inc
14/05/202422h15GlobeNewswire Inc.Shattuck Labs to Present Additional Data from the Phase 1B Dose Expansion Clinical Trial of SL-172154 with Azacitidine (AZA) in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) Patients at the EuNASDAQ:STTKShattuck Labs Inc
14/05/202422h02Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
02/05/202413h05GlobeNewswire Inc.Shattuck Labs Reports First Quarter 2024 Financial Results and Recent Business HighlightsNASDAQ:STTKShattuck Labs Inc
09/04/202422h05GlobeNewswire Inc.Shattuck Labs Announces Oral Presentation of Preclinical Data at the American Association for Cancer Research (AACR) Annual Meeting 2024NASDAQ:STTKShattuck Labs Inc
01/04/202413h00GlobeNewswire Inc.Shattuck Labs Announces Participation in Upcoming 23rd Annual Needham Virtual Healthcare ConferenceNASDAQ:STTKShattuck Labs Inc
08/03/202423h29Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:STTKShattuck Labs Inc
06/03/202422h42Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:STTKShattuck Labs Inc
04/03/202413h14Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:STTKShattuck Labs Inc
04/03/202413h00GlobeNewswire Inc.Shattuck Labs Announces Appointment of Clay Siegall, Ph.D., and Kate Sasser, Ph.D., to its Board of DirectorsNASDAQ:STTKShattuck Labs Inc
29/02/202422h41Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:STTKShattuck Labs Inc
29/02/202422h23Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:STTKShattuck Labs Inc
29/02/202422h05GlobeNewswire Inc.Shattuck Labs Reports Fourth Quarter and Full-Year 2023 Financial Results and Recent Business HighlightsNASDAQ:STTKShattuck Labs Inc
26/02/202413h00GlobeNewswire Inc.Shattuck Labs Announces Participation in Upcoming March ConferencesNASDAQ:STTKShattuck Labs Inc
14/02/202411h06PR Newswire (US)Ono Enters into a Drug Discovery Collaboration and Option Agreement with Shattuck Labs to Generate Bifunctional Fusion ProteinsNASDAQ:STTKShattuck Labs Inc
13/02/202412h00GlobeNewswire Inc.Shattuck Labs Enters into Strategic Collaboration and License Agreement with Ono Pharmaceutical to Generate Bifunctional Fusion Proteins for the Treatment of Autoimmune and Inflammatory DiseasesNASDAQ:STTKShattuck Labs Inc
02/02/202422h32Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:STTKShattuck Labs Inc
01/02/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:STTKShattuck Labs Inc
24/01/202422h31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:STTKShattuck Labs Inc
08/01/202413h00GlobeNewswire Inc.Shattuck Labs Provides Corporate Update and Highlights Upcoming Key Milestones in 2024NASDAQ:STTKShattuck Labs Inc
04/01/202422h05GlobeNewswire Inc.Shattuck Labs Announces Presentation at Upcoming 42nd Annual J.P. Morgan Healthcare ConferenceNASDAQ:STTKShattuck Labs Inc
22/12/202322h00Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:STTKShattuck Labs Inc
21/12/202314h00GlobeNewswire Inc.Shattuck Labs Announces $50 Million Public Offering of Common Stock and Concurrent Private Placement of Pre-Funded WarrantsNASDAQ:STTKShattuck Labs Inc
13/12/202315h00AllPennyStocks.comSmall Cap Steals The Show With Wild Premarket ActionNASDAQ:STTKShattuck Labs Inc
13/12/202312h00GlobeNewswire Inc.Shattuck Labs Announces Positive Initial Topline Data from Ongoing Phase 1 A/B Dose Expansion Clinical Trial of SL-172154 with Azacitidine in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53 mutant (TP53m) Acute Myeloid Leukemia (AML) PatiNASDAQ:STTKShattuck Labs Inc
05/12/202322h15GlobeNewswire Inc.Shattuck Labs to Host Investor Call and Webcast to Share Initial Clinical Trial Data from Phase 1A/B Dose-Expansion Cohorts in Frontline Higher-Risk Myelodysplastic Syndromes (HR-MDS) and TP53m Acute Myeloid Leukemia (AML) and Review of Dose-Escalation DatNASDAQ:STTKShattuck Labs Inc
14/11/202315h00GlobeNewswire Inc.Shattuck Labs Announces Participation in Upcoming 6th Annual Evercore ISI HealthCONx ConferenceNASDAQ:STTKShattuck Labs Inc
09/11/202313h03Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:STTKShattuck Labs Inc
09/11/202312h00GlobeNewswire Inc.Shattuck Labs Reports Third Quarter 2023 Financial Results and Recent Business HighlightsNASDAQ:STTKShattuck Labs Inc
06/11/202315h28GlobeNewswire Inc.Shattuck Labs to Report Third-Quarter 2023 Financial Results on November 9, 2023NASDAQ:STTKShattuck Labs Inc
 Showing the most relevant articles for your search:NASDAQ:STTK

Dernières Valeurs Consultées

NASDAQ
AMZN
Amazon.com
SPI
SP500
S&P 500
EU
VIV
Vivendi
EU
GLE
Societe Generale
NYSE
MCD
McDonalds
NYSE
KO
Coca Cola
EU
AI
Air Liquide
EU
MC
Lvmh Moet Hennessy Louis...
EU
BEL20
Bel 20
EU
EN
Bouygues
FTSE
UKX
FTSE 100
NYSE
MRK
Merck
EU
DG
Vinci
EU
RNO
Renault
USI
USTECH100
US Tech 100
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés